Mid-Afternoon Market Update: Gold Drops 1%; Sprague Resources Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.89% to 32,953.50 while the NASDAQ fell 2.44% to 12,016.38. The SP also fell, dropping, 1.52% to 4,113.52. Also check this: Home Depot And 2 Other Stocks Insiders Are Buying Leading and Lagging Sectors Energy shares jumped by 1.1% on Friday. Meanwhile, top gainers in the sector included Sprague Resources LP (NYSE: SRLP ), up 20% and Nine Energy Service, Inc. (NYSE: NINE ) up 11%. In trading on Friday, consumer discretionary shares fell 2.7%. Top Headline The US economy added 390,000 jobs in May, above market estimates of 325,000. The unemployment rate, however, came in unchanged at 3.6% in May. Equities Trading UP Turning Point Therapeutics, Inc. (NASDAQ: TPTX ) shares shot up 117% to $74.00 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX ) got a boost, shooting 21% to $11.81 after the company announced the FDA …
Mid-Afternoon Market Update: Gold Drops 1%; Sprague Resources Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.89% to 32,953.50 while the NASDAQ fell 2.44% to 12,016.38. The SP also fell, dropping, 1.52% to 4,113.52. Also check this: Home Depot And 2 Other Stocks Insiders Are Buying Leading and Lagging Sectors Energy shares jumped by 1.1% on Friday. Meanwhile, top gainers in the sector included Sprague Resources LP (NYSE: SRLP ), up 20% and Nine Energy Service, Inc. (NYSE: NINE ) up 11%. In trading on Friday, consumer discretionary shares fell 2.7%. Top Headline The US economy added 390,000 jobs in May, above market estimates of 325,000. The unemployment rate, however, came in unchanged at 3.6% in May. Equities Trading UP Turning Point Therapeutics, Inc. (NASDAQ: TPTX ) shares shot up 117% to $74.00 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX ) got a boost, shooting 21% to $11.81 after the company announced the FDA …